English हिन्दी
Connect with us

Health

Sputnik Light single-dose jab gets approval for emergency use: Which all Covid vaccines are available in India? All you need to know

Sputnik Light is the second Covid-19 vaccine to be made available in India by Dr Reddy. Check the list of all Covid 19 vaccine available in India.

Published

on

Sputnik Light Covid-19 vaccine

Dr Reddy’s Laboratories Ltd stated that the Drugs Controller General of India (DCGI) has approved the single-shot Sputnik Light vaccination for Covid-19 in India for restricted use in emergency situations.

Mansukh Mandaviya, the Union Health Minister, released this statement, saying it will help the country battle the pandemic even more effectively. It is 80 percent effective against the infection, higher than that of most two-shot vaccines.

Sputnik Light is the second Covid-19 vaccine to be made available in India by Dr Reddy and has been approved in over 30 countries around the world including Russia, UAE, Argentina, and the Philippines.

Apart from this, there are several vaccines that are approved in India for use. Check the list here.

Sputnik Light

Sputnik Light, the first component of Sputnik V, developed by Dr Reddy, is a safe and approved stand-alone one-shot vaccine. Sputnik Light is also a leading booster shot for people previously infected with Covid-19 and for revaccinations after Sputnik V or other vaccines.

It is 70 percent effective against the Delta variant and over 70 percent efficacy in the age group below 60. Sputnik Light as a booster increases virus-neutralizing activity against the Omicron variant considerably.

Covaxin

Covaxin is India’s indigenous Covid-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). It demonstrated 77.8 percent vaccine efficacy against symptomatic Covid-19 disease.

Vaccine efficacy against severe disease is 93 percent. In adults aged less than 60 years, efficacy was 79 percent; and in those aged 60 years and over it was 68 percent. Vaccine efficacy against all variant-related Covid-19 disease was 71 percent with an efficacy of 90 percent against Kappa, and 65 percent against Delta.

Covishield

‍Covishield is the Covid 19 vaccine developed by Oxford Astra Zeneca, manufactured at the Serum Institute of India. The efficacy of the Covishield vaccine is 70 percent after the patient is administered with both doses.

Two doses of the vaccine are given four to twelve weeks apart. It can be kept safe at temperatures ranging from 2 to 8 degrees Celsius and is easily accessible.

Corbevax

Corbevax is a recombinant protein subunit vaccine. It is India’s first indigenously developed receptor-binding domain (RBD) protein subunit vaccine against Covid-19, made by Hyderabad-based firm Biological-E.

The vaccine will be effective both in scale and affordability, providing sustainable access to low-and middle-income countries.

Covovax

Covovax is an American vaccine developed by the Serum Institute of India (SII) in Pune, received FDA approval alongside Corbevax. According to the company, the vaccine was more than 90 percent effective in a late-stage clinical trial conducted in the United States.

Johnson & Johnson

Johnson & Johnson has issued an Emergency Use Authorization (EUA) for its single-dose Covid-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent Covid-19 in individuals 18 years of age and older.

The vaccine was 85 percent effective in preventing severe disease across all regions studied, and showed protection against Covid-19 related hospitalization and death, beginning 28 days after vaccination.

Sputnik

Sputnik V is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world’s first registered combination vector vaccine for the prevention of Covid-19.

The two doses of V Light Vaccine have a 91.6 percent efficacy rate. The single-dose effectiveness rate is 79.4 percent. The Sputnik vaccine, unlike other similar vaccinations, employs two slightly different forms of the vaccine for the first and second doses, which are given 21 days apart.

Read Also: AIIMS Raipur Recruitment 2022 Notification released, know website to apply, important dates, more information

ZyCov D

ZyCov D is India’s first needle-free and second indigenous Covid-19 vaccine which was recently launched in Bihar’s Patna. It is the world’s first DNA vaccine manufactured by Zydus Cadila.

It’s a three-dose vaccine and it is to be administered intradermally using the painless PharmaJet needle-free system called Tropis on day 0, day 28, and day 56.

Health

India registers 313 new Covid cases, active cases reach 2,041, 3 deaths recorded in last 24 hours

The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a rise in the hospitalization and mortality.

Published

on

India saw a single-day rise of 313 new Covid cases, while the active caseload has declined to 2,041, the health ministry said on Saturday.  Three deaths: two from Karnataka and one from Maharashtra were reported in the last 24 hours.

According to the ministry website, the number of active cases in the country stood at 2,331 on Friday. The number of cases of Covid had dropped to double digits till December 5, but it began to start increasing after the emergence of a new variant and cold weather conditions.

 According to reports after December 5, the highest single day rise of 841new cases was reported on December 31, 2023, which is 0.2% of the peak cases reported in May 2021. Of the total active cases, a large majority of these (around 92%) are recovering under home isolation.

The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a rise in the hospitalization and mortality. India has witnessed three waves of Covid in the past with its peak incidence of daily new cases and deaths being reported during the delta wave in April June 2021.

 At its peak, 414,188 new cases and 3915 deaths were reported on May 7, 2021. Since the pandemic started in early 2020, there have have been 4.5 crore people who have got infected and this has resulted in the death of 5.3 lakh persons in a total time span of four years.

According to the ministry data, the total number of persons who have recuperated from the disease are 4.4 crore with total recovery rate recorded is 98.81%. A total number of 220.67 crore doses of Covid vaccines have been administered in India so far.  

Continue Reading

Health

India registers 605 new COVID-19 cases and 4 deaths in last 24 hours

The number of people who have recovered from the disease has gone up to 4,44,81,341, an increase of 648 since Sunday morning. In Kerala a 70 year-old male with chronic obstructive pulmonary disease (COPD) and 81year-old male with T2DM and HTN, and in Karnataka, a 48 year old male with CA and TB died, while one person in Tripura succumbed to COVID.

Published

on

India recorded 605 fresh COVID-19 cases and four deaths in the last 24 hours. The active cases have increased to 4002, while India’s overall COVID case tally stands at over 4.5 crore (4,50,18,792). The death toll was recorded at 5,33,396 with four new deaths – two from Kerala and one each in Karnataka and Tripura – reported in the last 24 hours, the data updated at 8am stated.

The number of people who have recovered from the disease has gone up to 4,44,81,341, an increase of 648 since Sunday morning. In Kerala a 70 year-old male with chronic obstructive pulmonary disease (COPD) and 81year-old male with T2DM and HTN, and in Karnataka, a 48 year old male with CA and TB died, while one person in Tripura succumbed to COVID.

The Indian Council of Medical Research (ICMR) reported that 11,838 doses of the vaccine had been administered in the country till January 7. The data is a compilation of the Integrated Disease Surveillance Programme (National Centre for Disease Control), media bulletins and websites of various states at 8am on January 4.

As the winter season sets in, health experts are highlighting a sudden surge in viral infections, influenza, and COVID-19 cases. Dr Nikhil Modi, a senior pulmonologist at Indraprastha Apollo Hospital, pointed out that the decrease in temperature leads to increase in moisture in the air, low wind speed and also causes an increase in pollution levels. This contributes highly to various infections.

Due to the decrease in temperature the fog combines with the pollution in the air which further leads to the formation of smog. This condition of the atmosphere can cause different types of infections and difficulty in breathing. Both the state and the central government are keeping a close watch on the new Omicron Subvariant JN.1. J.N.1 is a Variant of Interest (VOI) which is under intense scientific scrutiny.   

Continue Reading

Health

India records 774 new Covid-19 cases, 2 deaths in 24 hours

The number of daily cases was in double digits till December 5 but it started to rise again amid cold weather conditions and after the emergence of new Covid-19 variant, JN.1.

Published

on

India on Saturday had a single-day rise of 774 Covid cases while the number of active cases stood at 4,187, the Union health ministry said. As many as two deaths – one each from Tamil Nadu and Gujarat were reported in a span of 24 hours. Of the 4,187 active cases, the majority (over 92%) are recovering under home isolation.

The number of daily cases was in double digits till December 5 but it started to rise again amid cold weather conditions and after the emergence of new Covid-19 variant, JN.1. The central government has asked the state government and union territories to maintain a constant vigil amid an upward trend in the number of Covid-cases and the detection of the JN.1 sub variant in the country.

According to reports after December 5, the highest single-day rise of 841 cases was reported on December 31, 2023, which was 0.2% of the peak cases reported in May 2021. A health official said that the JN.1 variant is neither leading to an exponential rise in new cases nor a surge in hospitalisation and mortality in the country.

The Karnataka government has made the Covid test mandatory for those with Influenza like illness (ILI) or Severe Acute Respiratory Illness (SARI). Karnataka Health Minister Dinesh Gundu Rao said more than 7000 tests are being done every day and the COVID positivity rate is 3.82%. The positivity rate in the state has not come down yet.

He said those with symptoms are being monitored and tested. Those who are in isolation at home have been told to take extra care. He added it is expected that the trend of decreasing Covid cases may start next week in Karnataka. India has witnessed three waves of Covid-19 in the past with the peak incidence of daily cases and deaths being reported during the Delta wave during April-June 2021. At its peak 4,14,188 cases and 3915 deaths were reported on May 7, 2021.

Continue Reading

Trending

-->

© Copyright 2022 APNLIVE.com